Precipio Past Earnings Performance
Past criteria checks 0/6
Precipio has been growing earnings at an average annual rate of 15.5%, while the Healthcare industry saw earnings growing at 7% annually. Revenues have been growing at an average rate of 31.3% per year.
Key information
15.5%
Earnings growth rate
71.5%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 31.3% |
| Return on equity | -40.6% |
| Net Margin | -38.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Investors Holding Back On Precipio, Inc. (NASDAQ:PRPO)
Mar 29
Precipio, Inc.'s (NASDAQ:PRPO) Subdued P/S Might Signal An Opportunity
Aug 29Precipio to distribute HemeScreen through Fisher Healthcare channel
Jul 20Precipio terminates its equity line with Lincoln Park
Jun 15We Think Some Shareholders May Hesitate To Increase Precipio, Inc.'s (NASDAQ:PRPO) CEO Compensation
Jun 12Precipio shares surge on HemeScreen Anemia Panel launch
Jun 08Precipio shares surge on launching hemescreen panel for Acute Myeloid Leukemia
May 10Precipio: COVID-19 Testing At Amazon Is An Impressive Yet Transitory Fluke
May 05Precipio shares jump on launching its rapid COVID-19 antibody test on Amazon platform
May 03Revenue & Expenses BreakdownBeta
How Precipio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 15 | -6 | 14 | 0 |
| 30 Sep 23 | 13 | -9 | 14 | 0 |
| 30 Jun 23 | 11 | -11 | 14 | 0 |
| 31 Mar 23 | 10 | -11 | 14 | 0 |
| 31 Dec 22 | 9 | -12 | 15 | 0 |
| 30 Sep 22 | 9 | -12 | 16 | 0 |
| 30 Jun 22 | 9 | -11 | 15 | 0 |
| 31 Mar 22 | 9 | -12 | 15 | 0 |
| 31 Dec 21 | 9 | -9 | 12 | 0 |
| 30 Sep 21 | 8 | -8 | 11 | 0 |
| 30 Jun 21 | 8 | -10 | 11 | 0 |
| 31 Mar 21 | 7 | -9 | 11 | 0 |
| 31 Dec 20 | 6 | -14 | 10 | 0 |
| 30 Sep 20 | 5 | -16 | 10 | 0 |
| 30 Jun 20 | 4 | -14 | 10 | 0 |
| 31 Mar 20 | 4 | -18 | 10 | 0 |
| 31 Dec 19 | 3 | -13 | 10 | 0 |
| 30 Sep 19 | 3 | -16 | 9 | 0 |
| 30 Jun 19 | 3 | -18 | 9 | 0 |
| 31 Mar 19 | 3 | -16 | 9 | 0 |
| 31 Dec 18 | 3 | -20 | 9 | 0 |
| 30 Sep 18 | 3 | -26 | 10 | 0 |
| 30 Jun 18 | 3 | -33 | 10 | 0 |
| 31 Mar 18 | 2 | -38 | 8 | 0 |
| 31 Dec 17 | 2 | -33 | 6 | 0 |
| 30 Sep 17 | 1 | -21 | 5 | 0 |
| 30 Jun 17 | 1 | -11 | 3 | 0 |
| 31 Mar 17 | 1 | -3 | 3 | 0 |
| 31 Dec 16 | 2 | -4 | 2 | 0 |
| 31 Dec 15 | 1 | -2 | 2 | 0 |
Quality Earnings: PRPO is currently unprofitable.
Growing Profit Margin: PRPO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PRPO is unprofitable, but has reduced losses over the past 5 years at a rate of 15.5% per year.
Accelerating Growth: Unable to compare PRPO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PRPO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (9.2%).
Return on Equity
High ROE: PRPO has a negative Return on Equity (-40.56%), as it is currently unprofitable.